A systematic review of the associations between dose regimens and medication compliance

Clinical Therapeutics

Volumn 23, Issue 8, 2001, Pages 1296-1310

  Claxton, Ami J ^a   Cramer, Joyce ^c   Pierce, Courtney ^a,b  

^a ELI LILLY AND COMPANY   (United States)

^b INDIANA UNIVERSITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adherence; Compliance; Dosing regimen; Electronic monitoring; MEMS

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ATENOLOL; BETAXOLOL; FLUINDOSTATIN; FLUOXETINE; METHOTREXATE; PHENOBARBITAL;

DOSE RESPONSE; MONITORING; PATIENT COMPLIANCE; PILL; PRESCRIPTION; REVIEW;

EID: 0034871011     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(01)80109-0     Document Type: Article

References (95)

1. Improvement of medication compliance in uncontrolled hypertension
2. Ascertaining how much compliance is enough with outpatient antibiotic regimens
3. How often is medication taken as prescribed?
4. The natural history of medication compliance in a drug trial: Limitations of pill counts
5. Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily
6. Overview of patient compliance with medication dosing: A literature review
7. Compliance with topical timolol treatment
8. Compliance with topical pilocarpine treatment
9. The effect of prescribed daily dose frequency on patient medication compliance
10. The effect of medication compliance on the control of hypertension
11. The paradox of using a 7 day antibacterial course to treat urinary tract infections in the community
12. Adherence to single daily dose of aspirin in a chemoprevention trial: An evaluation of self-report and microelectronic monitoring
13. Electronic monitoring of participant adherence in the NSABP breast cancer prevention trial
14. Electronic measurement of compliance with mercaptopurine in pediatric patients with acute lymphoblastic leukemia
15. Patient compliance with prolonged oral altretamine treatment in relapsed ovarian cancer
16. Adherence to oral tamoxifen: A comparison of patient self-report, pill counts, and microelectronic monitoring
17. Patient compliance with once-daily and twice-daily oral formulations of 5-isosorbide mononitrate: A comparative study
18. Objective monitoring of drug compliance: An important step in the management of hypertension resistant drug therapy
19. Major depression and medication adherence in elderly patients with coronary artery disease
20. Patient compliance and therapeutic coverage: Comparison of amlodipine and slow release nifedipine in the treatment of hypertension
21. Antihypertensive medication-taking. Investigation of a simple regimen
22. Actual versus prescribed timing of lovastatin doses assessed by electronic compliance monitoring
23. Measurement of drug compliance by continuous electronic monitoring: A pilot study in elderly patients discharged from hospital
24. Patterns of drug compliance with medications to be taken once and twice daily assessed by continuous electronic monitoring in primary care
25. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study
26. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: A randomized clinical trial using electronic monitoring
27. Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension
28. Use of a microprocessor-equipped tablet box in monitoring compliance with antihypertensive treatment
29. Behavior of patients with mild-to-moderate arterial hypertension in relation to their treatment. Contribution of an electronic pillbox
30. Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension
31. Compliance, electronic monitoring and antihypertensive drugs
32. The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening
33. Compliance and antihypertensive efficacy of amlodipine compared with nifedipine slow-release
34. Improved compliance measures: Applications in an ambulatory hypertensive drug trial
35. Antihypertensive drug trials, contributions from medication monitors
36. Gaps in cardiovascular medication taking: The tip of the iceberg
37. Patient self-reporting of compliance does not correspond with electronic monitoring: An evaluation using isosorbide dinitrate as a model drug
38. Measuring patient compliance with electronic monitoring: Lisinopril versus atenolol in essential hypertension
39. Use of drugs with more than a twenty-four-hour duration of action
40. Effects of treatment with oral isosorbide dinitrate on platelet function in vivo; a double-blind placebo-controlled study in patients with stable angina pectoris
41. Transdermal clonidine as an adjunct to enalapril: An evaluation of efficacy and patient compliance
42. Compliance declines between clinic visits
43. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial
44. Compliance with short-term high-dose ethinyl oestradiol in young patients with primary infertility. New insights from the use of electronic devices
45. Dosage frequency and drug-compliance behaviour - A comparative study on compliance with a medication to be taken twice or four times daily
46. Compliance and adverse drug reactions: A prospective study with ethinyl-estradiol using continuous compliance monitoring
47. Measuring compliance among oral contraceptive users
48. Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone
49. Compliance with doxycycline therapy in sexually transmitted diseases clinics
50. Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis
51. Relationship between the prescriber's instructions and compliance with antibiotherapy in outpatients treated for an acute infectious disease
52. Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial
53. Medication adherence in patients with HIV infection: A comparison of two measurement methods
54. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics
55. Adherence to zidovudine (AZT) among HIV-infected methadone patients: A pilot study of supervised therapy and dispensing compared to usual care
56. Adherence with twice-daily dosing of inhaled steroids: Socioeconomic and health-belief differences
57. Compliance with inhaled medications: The relationship between diary and electronic monitor
58. The psychological factors associated with poor compliance with treatment in asthma
59. Compliance in clinical trials of two nonbronchodilator, antiasthma medications
60. Noncompliance and treatment failure in children with asthma
61. Multiple dose regimens. Impact on compliance
62. Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog
63. A nebulizer chronolog to monitor compliance with inhaler use
64. Trying to improve compliance with prophylactic penicillin therapy in children with sickle cell disease
65. Compliance monitoring of NSAID drug therapy in ankylosing spondylitis, experiences with an electronic monitoring device
66. Patient compliance with anti-rheumatic drug therapy in RA: Experiences with an electronic monitoring device
67. Adherence to iron supplementation during pregnancy in Tanzania: Determinants and hematologic consequences
68. Dynamics of drug regimen compliance - Its assessment by microprocessor-based monitoring
69. Assessment of sulfonylurea adherence and metabolic control
70. Clinical use of the Medication Event Monitoring System: A new window into pediatric compliance
71. Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator
72. Pharmacists' interventions using an electronic medication-event monitoring device's adherence data versus pill counts
73. Compliance assessed by the Medication Event Monitoring System
74. Iron-chelation therapy with oral deferiprone in patients with thalassemia major
75. Impact of dosage frequency on patient compliance
76. Prediction of diltiazem plasma concentration curves from limited measurements using compliance data
77. Enhancing medication compliance for people with serious mental illness
78. Compliance in depressed patients treated with fluoxetine or amitriptyline
79. The effects of monitoring and feedback on compliance
80. Measurement of compliance with naltrexone in the treatment of alcohol dependence: Research and clinical implications
81. Introducing medical students to medication noncompliance
82. Drug-taking compliance: A review and synthesis
83. From compliance to alliance: A quarter century of research
84. Consequences of intermittent treatment for hypertension: The case for medication compliance and persistence
85. Compliance during treatment with antidepressants
86. Role of patient compliance in clinical pharmacokinetics: A review of recent research
87. The effect of microelectronic observation on compliance
88. A study design for comparing the effects of missing daily doses of antihypertensive drugs
89. Selective serotonin reuptake inhibitor discontinuation syndrome: A randomized clinical trial
90. A comparison of fluvastatin 40 mg every other day versus 20 mg every day in patients with hypercholesterolemia
91. Effects of weekly iron supplementation on pregnant Indonesian women are similar to those of daily supplementation
92. Daily versus weekly: How many pills do pregnant women need?
93. Electronic monitoring of travellers' adherence to mefloquine malaria chemoprophylaxis